BackAkoya Biosciences Overview

Akoya Biosciences Total Assets

Akoya Biosciences's total assets is $110M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$112.65M
↓ 27.21% YoYΔ $-42.10M vs prior year quarter

Peer trimmed avg / median

Loading

Akoya Biosciences Total Assets History

Loading

Akoya Biosciences vs. peers: Total Assets Comparison

Loading

Akoya Biosciences Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Akoya Biosciences (AKYA) FAQ

Akoya Biosciences's total assets stands at $110M as of March 2025. That compares with $150M in the prior-year period — down 27.2% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Akoya Biosciences reported $110M in total assets versus $150M a year earlier — a 27.2% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $150M in the prior-year period — down 27.2% year over year. Sustained growth in total assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Akoya Biosciences's total assets evolved across reporting periods, while the comparison chart places AKYA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, total assets is commonly used to spot outliers. Akoya Biosciences's reading of $110M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.